HP
COLL icon

HealthInvest Partners’s Collegium Pharmaceutical COLL Stock Holding History

HealthInvest Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-480,000
Closed -$9.61M – 16
2020
Q4 		$9.61M Buy
+480,000
New +$9.37M 6.37% 5

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HealthInvest Partners's COLL Position: Q1 2021 in Review

HealthInvest Partners sold out of Collegium Pharmaceutical (COLL) in Q1 2021, closing a stake of 480,000 shares — an estimated $9.61M sold.

HealthInvest Partners first reported a position in COLL in Q4 2020 and held it in 1 quarter. The position peaked at $9.61M in Q4 2020. 163 funds tracked by Wall St. Rank hold COLL as of Q1 2021.

  • HealthInvest Partners reported no remaining Collegium Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • HealthInvest Partners sold 480,000 Collegium Pharmaceutical shares in Q1 2021, an estimated $9.61M.
  • HealthInvest Partners first reported a position in Collegium Pharmaceutical in Q4 2020 and held it in 1 quarter.
  • HealthInvest Partners's Collegium Pharmaceutical position peaked at $9.61M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2021.

Based on HealthInvest Partners's 13F filing for Q1 2021, filed 30 Apr 2021.